Bristol urges combo hepatitis C study with Gilead

(Reuters) - Bristol-Myers Squibb Co renewed calls for biotechnology company Gilead Sciences Inc to test one of its hepatitis C drugs in late-stage trials alongside Bristol's own promising medicine, fo…
Read the full story: Reuters: Health News